Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.03
GB's Cash to Debt is ranked lower than
98% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 3.05 vs. GB: 0.03 )
Ranked among companies with meaningful Cash to Debt only.
GB' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.20 Max: N/A
Current: 0.03
Equity to Asset 0.25
GB's Equity to Asset is ranked lower than
88% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. GB: 0.25 )
Ranked among companies with meaningful Equity to Asset only.
GB' s Equity to Asset Range Over the Past 10 Years
Min: 0.25  Med: 0.54 Max: 0.75
Current: 0.25
0.25
0.75
Interest Coverage 0.25
GB's Interest Coverage is ranked lower than
100% of the 191 Companies
in the Global Medical Devices industry.

( Industry Median: 50.91 vs. GB: 0.25 )
Ranked among companies with meaningful Interest Coverage only.
GB' s Interest Coverage Range Over the Past 10 Years
Min: 0.05  Med: 3.19 Max: 17.79
Current: 0.25
0.05
17.79
F-Score: 3
Z-Score: 0.80
M-Score: -2.19
WACC vs ROIC
6.24%
1.30%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) 1.53
GB's Operating margin (%) is ranked lower than
51% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 2.36 vs. GB: 1.53 )
Ranked among companies with meaningful Operating margin (%) only.
GB' s Operating margin (%) Range Over the Past 10 Years
Min: 0.2  Med: 7.32 Max: 12.93
Current: 1.53
0.2
12.93
Net-margin (%) -2.91
GB's Net-margin (%) is ranked lower than
56% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.77 vs. GB: -2.91 )
Ranked among companies with meaningful Net-margin (%) only.
GB' s Net-margin (%) Range Over the Past 10 Years
Min: -1.72  Med: 5.09 Max: 8.06
Current: -2.91
-1.72
8.06
ROE (%) -4.04
GB's ROE (%) is ranked lower than
58% of the 297 Companies
in the Global Medical Devices industry.

( Industry Median: 0.98 vs. GB: -4.04 )
Ranked among companies with meaningful ROE (%) only.
GB' s ROE (%) Range Over the Past 10 Years
Min: -2.39  Med: 5.50 Max: 9.6
Current: -4.04
-2.39
9.6
ROA (%) -1.61
GB's ROA (%) is ranked lower than
54% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: -0.34 vs. GB: -1.61 )
Ranked among companies with meaningful ROA (%) only.
GB' s ROA (%) Range Over the Past 10 Years
Min: -1.07  Med: 2.76 Max: 6.01
Current: -1.61
-1.07
6.01
ROC (Joel Greenblatt) (%) 4.86
GB's ROC (Joel Greenblatt) (%) is ranked higher than
51% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 4.10 vs. GB: 4.86 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
GB' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 0.69  Med: 19.71 Max: 25.97
Current: 4.86
0.69
25.97
Revenue Growth (3Y)(%) 3.50
GB's Revenue Growth (3Y)(%) is ranked lower than
51% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 3.70 vs. GB: 3.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
GB' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0.8  Med: 6.95 Max: 30.3
Current: 3.5
0.8
30.3
EBITDA Growth (3Y)(%) -7.70
GB's EBITDA Growth (3Y)(%) is ranked lower than
66% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. GB: -7.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
GB' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -8.5  Med: 3.80 Max: 24.9
Current: -7.7
-8.5
24.9
EPS Growth (3Y)(%) 12.40
GB's EPS Growth (3Y)(%) is ranked higher than
62% of the 202 Companies
in the Global Medical Devices industry.

( Industry Median: 3.50 vs. GB: 12.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
GB' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -19.8  Med: 7.60 Max: 149
Current: 12.4
-19.8
149
» GB's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-07-30)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

GB Guru Trades in Q2 2015

Steven Cohen 165,800 sh (New)
Paul Tudor Jones 4,416 sh (New)
Ken Fisher 736,437 sh (+20.17%)
Chuck Royce Sold Out
Diamond Hill Capital 387,815 sh (-0.44%)
Mario Gabelli 137,200 sh (-15.83%)
Joel Greenblatt 43,533 sh (-81.98%)
» More
Q3 2015

GB Guru Trades in Q3 2015

Jim Simons 28,900 sh (New)
Paul Tudor Jones 6,787 sh (+53.69%)
Diamond Hill Capital 389,581 sh (+0.46%)
Steven Cohen Sold Out
Ken Fisher 701,373 sh (-4.76%)
Joel Greenblatt 34,282 sh (-21.25%)
Mario Gabelli 107,900 sh (-21.36%)
» More
Q4 2015

GB Guru Trades in Q4 2015

Steven Cohen 3,700 sh (New)
Paul Tudor Jones 19,557 sh (+188.15%)
Jim Simons Sold Out
Joel Greenblatt Sold Out
Ken Fisher 697,094 sh (-0.61%)
Mario Gabelli 91,200 sh (-15.48%)
Diamond Hill Capital 327,051 sh (-16.05%)
» More
Q1 2016

GB Guru Trades in Q1 2016

Jim Simons 72,100 sh (New)
Chuck Royce 150,000 sh (New)
Steven Cohen 113,300 sh (+2962.16%)
Mario Gabelli 164,380 sh (+80.24%)
Ken Fisher 971,756 sh (+39.40%)
Diamond Hill Capital 365,806 sh (+11.85%)
Paul Tudor Jones 6,825 sh (-65.10%)
» More
» Details

Insider Trades

Latest Guru Trades with GB

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:OISE:OSSRu, XSWX:TECN, SZSE:300216, NYSE:PEN, TSE:3360, SHSE:600587 » details
Traded in other countries:WGB.Germany,
Greatbatch Inc designs and manufactures critical components that help to advance medical device technology across various applications. The Company operates in two segments namely Greatbatch Medical and QiG Group.

Greatbatch Inc is a Delaware corporation was incorporated on July 11, 1997. The Company designs and manufactures critical components that help to advance medical device technology across various applications. The Company operates in two segments namely Greatbatch Medical and QiG Group. Greatbatch Medical designs and manufactures products where Greatbatch either owns the intellectual property or has unique manufacturing and assembly expertise. Its products include medical devices and components for the cardiac, neuromodulation, orthopaedics, portable medical, vascular and energy markets among others. The Greatbatch Medical segment also offers value-added assembly and design engineering services for medical devices that utilize its component products.. QiG segment develops medical device systems for some of healthcare's challenges and reflects Greatbatch's strategic evolution of its product offerings. Through the research and development professionals in QiG, the Company is now investing in three areas namely new medical device systems commercialization, collaborative programs with OEM customers, and strategic equity positions in start-up companies to grow a diversified and distinctive portfolio. The medical device systems developed by QiG are manufactured by Greatbatch Medical. The Company's customers include large multi-national original equipment manufacturers. The Company is subject to direct governmental regulation including the laws and regulations generally applicable to all businesses in the jurisdictions in which it operates.

Ratios

vs
industry
vs
history
Forward P/E 7.94
GB's Forward P/E is ranked higher than
96% of the 54 Companies
in the Global Medical Devices industry.

( Industry Median: 20.75 vs. GB: 7.94 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 1.30
GB's P/B is ranked higher than
78% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.69 vs. GB: 1.30 )
Ranked among companies with meaningful P/B only.
GB' s P/B Range Over the Past 10 Years
Min: 0.89  Med: 1.41 Max: 2.24
Current: 1.3
0.89
2.24
P/S 0.92
GB's P/S is ranked higher than
81% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 3.12 vs. GB: 0.92 )
Ranked among companies with meaningful P/S only.
GB' s P/S Range Over the Past 10 Years
Min: 0.71  Med: 1.13 Max: 2.81
Current: 0.92
0.71
2.81
POCF 26.93
GB's POCF is ranked lower than
68% of the 131 Companies
in the Global Medical Devices industry.

( Industry Median: 19.95 vs. GB: 26.93 )
Ranked among companies with meaningful POCF only.
GB' s POCF Range Over the Past 10 Years
Min: 4.69  Med: 10.81 Max: 113.96
Current: 26.93
4.69
113.96
EV-to-EBIT 114.53
GB's EV-to-EBIT is ranked lower than
92% of the 169 Companies
in the Global Medical Devices industry.

( Industry Median: 21.22 vs. GB: 114.53 )
Ranked among companies with meaningful EV-to-EBIT only.
GB' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.5  Med: 21.50 Max: 768.8
Current: 114.53
7.5
768.8
EV-to-EBITDA 32.99
GB's EV-to-EBITDA is ranked lower than
80% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 17.06 vs. GB: 32.99 )
Ranked among companies with meaningful EV-to-EBITDA only.
GB' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.5  Med: 11.80 Max: 47.7
Current: 32.99
5.5
47.7
Shiller P/E 43.41
GB's Shiller P/E is ranked lower than
53% of the 43 Companies
in the Global Medical Devices industry.

( Industry Median: 39.79 vs. GB: 43.41 )
Ranked among companies with meaningful Shiller P/E only.
GB' s Shiller P/E Range Over the Past 10 Years
Min: 21.75  Med: 40.57 Max: 68.52
Current: 43.41
21.75
68.52
Current Ratio 2.47
GB's Current Ratio is ranked lower than
56% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. GB: 2.47 )
Ranked among companies with meaningful Current Ratio only.
GB' s Current Ratio Range Over the Past 10 Years
Min: 1.6  Med: 3.13 Max: 8.42
Current: 2.47
1.6
8.42
Quick Ratio 1.23
GB's Quick Ratio is ranked lower than
74% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. GB: 1.23 )
Ranked among companies with meaningful Quick Ratio only.
GB' s Quick Ratio Range Over the Past 10 Years
Min: 0.79  Med: 1.87 Max: 6.93
Current: 1.23
0.79
6.93
Days Inventory 100.72
GB's Days Inventory is ranked higher than
67% of the 283 Companies
in the Global Medical Devices industry.

( Industry Median: 136.13 vs. GB: 100.72 )
Ranked among companies with meaningful Days Inventory only.
GB' s Days Inventory Range Over the Past 10 Years
Min: 86  Med: 102.41 Max: 123.14
Current: 100.72
86
123.14
Days Sales Outstanding 68.98
GB's Days Sales Outstanding is ranked higher than
51% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 69.05 vs. GB: 68.98 )
Ranked among companies with meaningful Days Sales Outstanding only.
GB' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.11  Med: 63.86 Max: 94.55
Current: 68.98
42.11
94.55
Days Payable 43.62
GB's Days Payable is ranked lower than
66% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 62.25 vs. GB: 43.62 )
Ranked among companies with meaningful Days Payable only.
GB' s Days Payable Range Over the Past 10 Years
Min: 27.39  Med: 37.68 Max: 60.2
Current: 43.62
27.39
60.2

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.06
GB's Price/Projected FCF is ranked higher than
79% of the 121 Companies
in the Global Medical Devices industry.

( Industry Median: 2.07 vs. GB: 1.06 )
Ranked among companies with meaningful Price/Projected FCF only.
GB' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.47  Med: 0.92 Max: 1.49
Current: 1.06
0.47
1.49
Price/Median PS Value 0.80
GB's Price/Median PS Value is ranked higher than
69% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 1.01 vs. GB: 0.80 )
Ranked among companies with meaningful Price/Median PS Value only.
GB' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.66  Med: 1.50 Max: 4.23
Current: 0.8
0.66
4.23
Earnings Yield (Greenblatt) (%) 0.91
GB's Earnings Yield (Greenblatt) (%) is ranked higher than
52% of the 318 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. GB: 0.91 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
GB' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.1  Med: 4.70 Max: 13.4
Current: 0.91
0.1
13.4
Forward Rate of Return (Yacktman) (%) -0.87
GB's Forward Rate of Return (Yacktman) (%) is ranked lower than
73% of the 115 Companies
in the Global Medical Devices industry.

( Industry Median: 6.77 vs. GB: -0.87 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
GB' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -2  Med: 10.60 Max: 25.7
Current: -0.87
-2
25.7

More Statistics

Revenue (TTM) (Mil) $971.3
EPS (TTM) $ -0.91
Beta1.11
Short Percentage of Float5.12%
52-Week Range $28.68 - 57.63
Shares Outstanding (Mil)30.80

Analyst Estimate

Dec16 Dec17
Revenue (Mil $)
EPS ($) 3.15 3.95
EPS without NRI ($) 3.15 3.95
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
» More Articles for GB

Headlines

Articles On GuruFocus.com
BlackBerry Seems To Be Making The Right Moves Mar 08 2014 
Diamond Hill Capital Buys EOG, BR, GB, TEVA, BGS, IWD, HCC Jan 20 2011 
Greatbatch Inc. Reports Operating Results (10-Q) Nov 09 2010 
Greatbatch Inc. Reports Operating Results (10-Q) Aug 10 2010 
Greatbatch Inc. Reports Operating Results (10-Q) May 12 2010 
Greatbatch Inc. Reports Operating Results (10-Q) Nov 10 2009 
Greatbatch Inc. Reports Operating Results (10-Q) Aug 11 2009 
Greatbatch Inc. Reports Operating Results (10-Q) May 12 2009 

More From Other Websites
GREATBATCH, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 25 2016
GREATBATCH, INC. Financials May 18 2016
Bridgewater Ditched Amazon, Cut Apple Stake, Bought Google In Q1 May 13 2016
GREATBATCH, INC. Files SEC form 10-Q, Quarterly Report May 10 2016
ETF’s with exposure to Greatbatch, Inc. : May 5, 2016 May 05 2016
Greatbatch Extends Its Relationship with WiTricity to Include Wireless Energy Transfer for... May 05 2016
Greatbatch (GB) Misses on Q1 Earnings & Sales, View Intact May 05 2016
Greatbatch, Inc. :GB-US: Earnings Analysis: Q1, 2016 By the Numbers May 04 2016
Greatbatch, Inc. breached its 50 day moving average in a Bearish Manner : GB-US : May 4, 2016 May 04 2016
Edited Transcript of GB earnings conference call or presentation 28-Apr-16 9:00pm GMT Apr 29 2016
Greatbatch reports 1Q loss Apr 28 2016
Greatbatch reports 1Q loss Apr 28 2016
Greatbatch Inc Earnings Call scheduled for 5:00 pm ET today Apr 28 2016
Greatbatch, Inc. Reports 2016 First Quarter Results Apr 28 2016
GREATBATCH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 28 2016
Greatbatch, Inc. Reports 2016 First Quarter Results Apr 28 2016
Q1 2016 Greatbatch Inc Earnings Release - After Market Close Apr 28 2016
Motif's bet on batteries Apr 14 2016
Greatbatch, Inc. to Host Q1 2016 Earnings Conference Call Thursday, April 28, 2016 at 5:00 p.m.... Apr 12 2016
GREATBATCH, INC. Files SEC form 8-K, Change in Directors or Principal Officers Apr 12 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)